Continental Controls Ltd vs Genomic Valley Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 13, 2026

Key Highlights

The Latest Trading Price of Continental Controls Ltd is ₹ 8.69 as of 13 Mar 15:30 . The P/E Ratio of Continental Controls Ltd changed from 82.1 on March 2025 to 82.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Genomic Valley Biotech Ltd changed from 694.2 on March 2024 to 50.1 on March 2025 . This represents a CAGR of -73.14% over 2 years The Market Cap of Continental Controls Ltd changed from ₹ 2.31 crore on March 2021 to ₹ 5.55 crore on March 2025 . This represents a CAGR of 19.16% over 5 yearsThe Market Cap of Genomic Valley Biotech Ltd changed from ₹ 10.6 crore on March 2024 to ₹ 17.9 crore on March 2025 . This represents a CAGR of 29.95% over 2 years The revenue of Continental Controls Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.05 crore. This represent the decline of 0% The revenue of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.05 crore as compare to the Sep '25 revenue of ₹ 0.09 crore. This represent the decline of -44.44% The ebitda of Continental Controls Ltd for the Dec '25 is ₹ -0.08 crore as compare to the Sep '25 ebitda of ₹ -0.02 crore. This represent the growth of 300% The ebitda of Genomic Valley Biotech Ltd for the Dec '25 is ₹ 0.01 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The net profit of Continental Controls Ltd changed from ₹ 0.03 crore to ₹ -0.08 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Genomic Valley Biotech Ltd changed from ₹ 0.13 crore to ₹ 0.01 crore over 7 quarters. This represents a CAGR of -76.91% The Dividend Payout of Continental Controls Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Genomic Valley Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Continental Controls Ltd

Continental Controls Limited, promoted by Onelife Capital Advisors Limited is engaged in the business of manufacturing of Thermal Overload Protectors.
It has a worldwide network, single sales office, a warehouse and a work force of over 60 people that sell a single product to about 80 customers in India and Abroad. Continental Controls Limited, incorporated in March, 1995 has taken over the partnership firm in April, 1993.
CCL's manufacturing facility is located at Silvassa to manufactre Thermal Overload Protectors was set up with technical knowhow from Ingenieur- Buero Sarzaeim, Germany.
It came out with a public issue in Dec.'95 to part-finance this project.
The commercial production of Overload Protectors commenced in 1996-97. During 1999-2000, the Company diversified into the business of Software Development.

About Genomic Valley Biotech Ltd

Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.

FAQs for the comparison of Continental Controls Ltd and Genomic Valley Biotech Ltd

Which company has a larger market capitalization, Continental Controls Ltd or Genomic Valley Biotech Ltd?

Market cap of Continental Controls Ltd is 5 Cr while Market cap of Genomic Valley Biotech Ltd is 7 Cr

What are the key factors driving the stock performance of Continental Controls Ltd and Genomic Valley Biotech Ltd?

The stock performance of Continental Controls Ltd and Genomic Valley Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Continental Controls Ltd and Genomic Valley Biotech Ltd?

As of March 13, 2026, the Continental Controls Ltd stock price is INR ₹8.68. On the other hand, Genomic Valley Biotech Ltd stock price is INR ₹25.13.

How do dividend payouts of Continental Controls Ltd and Genomic Valley Biotech Ltd compare?

To compare the dividend payouts of Continental Controls Ltd and Genomic Valley Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.